Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16865035 | 0.93 | ALDH1A1 (0.36) | ALDH1A1FAAHHSP90AA1PKMHTT | |
| SCHEMBL20964199 | 0.92 | MEN1 (0.39) | ALDH1A1FAAHHSP90AA1PKMHTT | |
| SCHEMBL15502179 | 0.89 | MEN1 (0.33) | ALDH1A1MEN1MAPTHPGDKMT2A | |
| SCHEMBL16865047 | 0.89 | ALDH1A1 (0.33) | ALDH1A1FAAHHSP90AA1PKMHTT | |
| SCHEMBL24304871 | 0.88 | ALDH1A1 (0.33) | ALDH1A1FAAHHSP90AA1PKMHTT | |
| SCHEMBL20022917 | 0.86 | ALDH1A1 (0.44) | ALDH1A1FAAHHSP90AA1PKMHTT | |
| SCHEMBL20022914 | 0.84 | ALDH1A1 (0.45) | ALDH1A1FAAHHSP90AA1PKMHTT | |
| SCHEMBL31301119 | 0.83 | L3MBTL1 (0.37) | ALDH1A1FAAHHTTATMMGLL | |
| SCHEMBL20347852 | 0.83 | L3MBTL1 (0.37) | ALDH1A1FAAHHTTATMMGLL | |
| SCHEMBL16017498 | 0.83 | ALDH1A1 (0.47) | ALDH1A1FAAHHSP90AA1PKMHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10930858-B2 | Nitrogen-containing compound and organic electroluminescence device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-02-23 | — | — | US | disclosed |
| US-20190131534-A1 | NITROGEN-CONTAINING COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190131534-A1 | NITROGEN-CONTAINING COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | NOS1, DNTT, NOS2 | ALDH1A1 2261/4885FAAH 4537/4885HSP90AA1 3282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.